TPI
UTHR icon

Trust Point Inc’s United Therapeutics UTHR Stock Holding History

Trust Point Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$359K Sell
662
-19
-3% -$10.7K 0.03% 296
2026
Q1 		$404K Sell
681
-27
-4% -$13.4K 0.04% 303
2025
Q4 		$345K Sell
708
-518
-42% -$241K 0.03% 333
2025
Q3 		$514K Buy
1,226
+283
+30% +$95.2K 0.04% 224
2025
Q2 		$271K Sell
943
-274
-23% -$81.9K 0.03% 317
2025
Q1 		$375K Sell
1,217
-480
-28% -$164K 0.03% 285
2024
Q4 		$599K Buy
1,697
+531
+46% +$195K 0.04% 256
2024
Q3 		$418K Buy
1,166
+257
+28% +$86.8K 0.03% 316
2024
Q2 		$290K Buy
+909
New +$241K 0.02% 384

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Trust Point Inc's UTHR Position: Q2 2026 in Review

Trust Point Inc reduced its United Therapeutics (UTHR) stake by 2.8% in Q2 2026, selling an estimated $10.7K and leaving 662 shares worth $359K. The position accounts for 0.03% of the portfolio, ranked #296.

Trust Point Inc first reported a position in UTHR in Q2 2024 and has held it in 9 quarters since. The position peaked at $599K in Q4 2024. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Trust Point Inc held 662 shares of United Therapeutics worth $359K as of Q2 2026.
  • Trust Point Inc sold 19 United Therapeutics shares in Q2 2026, an estimated $10.7K.
  • United Therapeutics made up 0.03% of Trust Point Inc's portfolio in Q2 2026, its #296 holding.
  • Trust Point Inc first reported a position in United Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Trust Point Inc's United Therapeutics position peaked at $599K in Q4 2024.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Trust Point Inc's 13F filing for Q2 2026, filed 8 Jul 2026.